Carcinogenesis, Vol. 21, No. 5, 921-927,
May 2000
© 2000 Oxford University Press
Molecular Epidemiology and Cancer Prevention |
Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis
1 The New York Hospital–Cornell Medical Center, 525 East 68th Street, New York, NY 10021,
2 College of Physicians and Surgeons, Columbia–Presbyterian Cancer Center and School of Public Health, Columbia University, New York, NY 10032,
3 The Strang Cancer Prevention Center, 428 East 72nd Street, New York, NY 10021 and
4 Rutgers University Laboratory for Cancer Research, 164 Frelinghuysen Road, Piscataway, NY 08854, USA
Epidemiological studies consistently indicate that consumption of fruits and vegetables lowers cancer risk in humans and suggest that certain dietary constituents may be effective in preventing colon cancer. Plant-derived phenolic compounds manifest many beneficial effects and can potentially inhibit several stages of carcinogenesis in vivo. In this study, we investigated the efficacy of several plant-derived phenolics, including caffeic acid phenethyl ester (CAPE), curcumin, quercetin and rutin, for the prevention of tumors in C57BL/6J-Min/+ (Min/+) mice. These animals bear a germline mutation in the Apc gene and spontaneously develop numerous intestinal adenomas by 15 weeks of age. At a dietary level of 0.15%, CAPE decreased tumor formation in Min/+ mice by 63%. Curcumin induced a similar tumor inhibition. Quercetin and rutin, however, both failed to alter tumor formation at dietary levels of 2%. Examination of intestinal tissue from the treated animals showed that tumor prevention by CAPE and curcumin was associated with increased enterocyte apoptosis and proliferation. CAPE and curcumin also decreased expression of the oncoprotein ß-catenin in the enterocytes of the Min/+ mouse, an observation previously associated with an antitumor effect. These data place the plant phenolics CAPE and curcumin among a growing list of anti-inflammatory agents that suppress Apc-associated intestinal carcinogenesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Winkelmann, D. Diehl, D. Oesterle, H. Daniel, and U. Wenzel The suppression of aberrant crypt multiplicity in colonic tissue of 1,2-dimethylhydrazine-treated C57BL/6J mice by dietary flavone is associated with an increased expression of Krebs cycle enzymes Carcinogenesis, July 1, 2007; 28(7): 1446 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Khan, F. Afaq, and H. Mukhtar Apoptosis by dietary factors: the suicide solution for delaying cancer growth Carcinogenesis, February 1, 2007; 28(2): 233 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gao, X. Liu, and B. Rigas Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress PNAS, November 22, 2005; 102(47): 17207 - 17212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Cai, M. Al-Fayez, R. G. Tunstall, S. Platton, P. Greaves, W. P. Steward, and A. J. Gescher The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice Mol. Cancer Ther., September 1, 2005; 4(9): 1287 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Volate, D. M. Davenport, S. J. Muga, and M. J. Wargovich Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin) Carcinogenesis, August 1, 2005; 26(8): 1450 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. J. van Breda, E. van Agen, S. van Sanden, T. Burzykowski, A. S. Kienhuis, J. C. S. Kleinjans, and J. H. M. van Delft Vegetables Affect the Expression of Genes Involved in Anticarcinogenic Processes in the Colonic Mucosa of C57Bl/6 Female Mice J. Nutr., August 1, 2005; 135(8): 1879 - 1888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Gagandeep, M Dhiman, E Mendiz, A R Rao, and R K Kale Chemopreventive effects of mustard (Brassica compestris) on chemically induced tumorigenesis in murine forestomach and uterine cervix Human and Experimental Toxicology, June 1, 2005; 24(6): 303 - 312. [Abstract] [PDF]
|
|
|
|
|
|
S. H. Javid, A. E. Moran, A. M. Carothers, M. Redston, and M. M. Bertagnolli Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer Carcinogenesis, March 1, 2005; 26(3): 587 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hishikawa, T. Nakaki, and T. Fujita Oral Flavonoid Supplementation Attenuates Atherosclerosis Development in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 442 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Garcea, D. P. Berry, D. J.L. Jones, R. Singh, A. R. Dennison, P. B. Farmer, R. A. Sharma, W. P. Steward, and A. J. Gescher Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 120 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D Lambert, J. Hong, G.-y. Yang, J. Liao, and C. S Yang Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations Am. J. Clinical Nutrition, January 1, 2005; 81(1): 284S - 291S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Scott and G. Loo Curcumin-induced GADD153 gene up-regulation in human colon cancer cells Carcinogenesis, November 1, 2004; 25(11): 2155 - 2164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Moran, D. H. Hunt, S. H. Javid, M. Redston, A. M. Carothers, and M. M. Bertagnolli Apc Deficiency Is Associated with Increased Egfr Activity in the Intestinal Enterocytes and Adenomas of C57BL/6J-Min/+ Mice J. Biol. Chem., October 8, 2004; 279(41): 43261 - 43272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Nair, K. V. K. Rao, R. Aalinkeel, S. Mahajan, R. Chawda, and S. A. Schwartz Inhibition of Prostate Cancer Cell Colony Formation by the Flavonoid Quercetin Correlates with Modulation of Specific Regulatory Genes Clin. Vaccine Immunol., January 1, 2004; 11(1): 63 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Ziegler, L. Rainwater, J. Whelan, and M. F. McEntee Dietary Resveratrol Does Not Affect Intestinal Tumorigenesis in ApcMin/+ Mice J. Nutr., January 1, 2004; 134(1): 5 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Conney Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture Cancer Res., November 1, 2003; 63(21): 7005 - 7031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Kettunen, A. S. L. Kettunen, and N. E. Rautonen Intestinal Immune Responses in Wild-Type and ApcMin/+ Mouse, a Model for Colon Cancer Cancer Res., August 15, 2003; 63(16): 5136 - 5142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Corpet and F. Pierre Point: From Animal Models to Prevention of Colon Cancer. Systematic Review of Chemoprevention in Min Mice and Choice of the Model System Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 391 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Mai, L. H. Colbert, D. Berrigan, S. N. Perkins, R. Pfeiffer, J. A. Lavigne, E. Lanza, D. C. Haines, A. Schatzkin, and S. D. Hursting Calorie Restriction and Diet Composition Modulate Spontaneous Intestinal Tumorigenesis in ApcMin Mice through Different Mechanisms Cancer Res., April 15, 2003; 63(8): 1752 - 1755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Perkins, R. D. Verschoyle, K. Hill, I. Parveen, M. D. Threadgill, R. A. Sharma, M. L. Williams, W. P. Steward, and A. J. Gescher Chemopreventive Efficacy and Pharmacokinetics of Curcumin in the Min/+ Mouse, a Model of Familial Adenomatous Polyposis Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 535 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Ireson, D. J. L. Jones, S. Orr, M. W. H. Coughtrie, D. J. Boocock, M. L. Williams, P. B. Farmer, W. P. Steward, and A. J. Gescher Metabolism of the Cancer Chemopreventive Agent Curcumin in Human and Rat Intestine Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 105 - 111. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Plummer, K. A. Hill, M. F. W. Festing, W. P. Steward, A. J. Gescher, and R. A. Sharma Clinical Development of Leukocyte Cyclooxygenase 2 Activity as a Systemic Biomarker for Cancer Chemopreventive Agents Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1295 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Sharma, H. R. McLelland, K. A. Hill, C. R. Ireson, S. A. Euden, M. M. Manson, M. Pirmohamed, L. J. Marnett, A. J. Gescher, and W. P. Steward Pharmacodynamic and Pharmacokinetic Study of Oral Curcuma Extract in Patients with Colorectal Cancer Clin. Cancer Res., July 1, 2001; 7(7): 1894 - 1900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. van den Berg, T. van Vliet, W. M. R. Broekmans, N. H. P. Cnubben, W. H. J. Vaes, L. Roza, G. R.M.M. Haenen, A. Bast, and H. van den Berg A Vegetable/Fruit Concentrate with High Antioxidant Capacity Has No Effect on Biomarkers of Antioxidant Status in Male Smokers J. Nutr., June 1, 2001; 131(6): 1714 - 1722. [Abstract] [Full Text]
|
|
|
|
|
|
G. P. Collett, C. N. Robson, J. C. Mathers, and F. C. Campbell Curcumin modifies Apcmin apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apcmin mice Carcinogenesis, May 1, 2001; 22(5): 821 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Sharma, C. R. Ireson, R. D. Verschoyle, K. A. Hill, M. L. Williams, C. Leuratti, M. M. Manson, L. J. Marnett, W. P. Steward, and A. Gescher Effects of Dietary Curcumin on Glutathione S-Transferase and Malondialdehyde-DNA Adducts in Rat Liver and Colon Mucosa: Relationship with Drug Levels1 Clin. Cancer Res., May 1, 2001; 7(5): 1452 - 1458. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Weyant, A. M. Carothers, N. N. Mahmoud, H. L. Bradlow, H. Remotti, R. T. Bilinski, and M. M. Bertagnolli Reciprocal Expression of ER{{alpha}} and ER{beta} Is Associated with Estrogen-mediated Modulation of Intestinal Tumorigenesis Cancer Res., March 1, 2001; 61(6): 2547 - 2551. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ireson, S. Orr, D. J. L. Jones, R. Verschoyle, C.-K. Lim, J.-L. Luo, L. Howells, S. Plummer, R. Jukes, M. Williams, et al. Characterization of Metabolites of the Chemopreventive Agent Curcumin in Human and Rat Hepatocytes and in the Rat in Vivo, and Evaluation of Their Ability to Inhibit Phorbol Ester-induced Prostaglandin E2 Production Cancer Res., February 1, 2001; 61(3): 1058 - 1064. [Abstract] [Full Text]
|
|